Coagulation Parameter Thresholds Associated with Non-Bleeding in the Eighth Hour of Adult Cardiac Surgical Post-Cardiotomy Extracorporeal Membrane Oxygenation
- PMID: 27578897
- PMCID: PMC5001524
Coagulation Parameter Thresholds Associated with Non-Bleeding in the Eighth Hour of Adult Cardiac Surgical Post-Cardiotomy Extracorporeal Membrane Oxygenation
Abstract
Excessive bleeding and allogeneic transfusion during adult post-cardiotomy venoarterial extracorporeal membrane oxygenation (ECMO) are potentially harmful and expensive. Balancing the inhibition of clotting and distinguishing surgical from non-surgical bleeding in post-operative period is difficult. The sensitivity of coagulation tests including Thromboelastography(®) (TEG) to predict chest tube drainage in the early hours of ECMO was examined with the use of receiver-operating characteristics (ROC). The results are useful to incorporate in clinical evidence-based algorithms to guide management decisions. In the eighth hour of ECMO, 26 of the 53 adult patients (49%) studied were identified as non-bleeders (less than 2.0 mL/kg/h). All had experienced various types of cardiac surgical procedures. Fifty-two percent were female and the group was 54 ± 19 (mean ± 1 SD) years old. The coagulation parameter threshold with the maximum sensitivity and specificity to predict non-bleeding at 8 hours on ECMO was the kaolin plus heparinase TEG maximum amplitude (KH-TEG MA) at a significant ROC threshold (t) > 50 mm. The activated partial thromboplastin time (aPTT) t < 49 seconds, KH-TEG alpha-angle t > 51°, and the kaolin activated clotting time (ACT) t < 148 seconds were sensitive predictors of non-bleeders. The whole-blood KH-TEG MA was superior to the plasma-based aPTT or International Normalization Ratio (INR) to predict bleeding in the eighth hour of ECMO. Using coagulation laboratory thresholds that predict non-bleeding can begin a process of identifying patients earlier that are likely to bleed. Awareness of these parameter thresholds may improve care through patient protection from unnecessary transfusion and prolonging the life of the ECMO circuit. An algorithm incorporating the ROC thresholds was created to help recognize surgical bleeding to minimize unnecessary transfusions.
Keywords: Thromboelastography; anticoagulation; blood component transfusion; coagulation; extracorporeal life support; extracorporeal membrane oxygenation; hemorrhage; receiver operating characteristics.
Figures




Similar articles
-
Anticoagulation Monitoring Strategies During Extracorporeal Membrane Oxygenation (ECMO) Therapy - Differences Between Simultaneously Obtained Coagulation Tests: A Retrospective Single-Center Cohort Study.J Intensive Care Med. 2025 Jun;40(6):651-659. doi: 10.1177/08850666241313357. Epub 2025 Feb 6. J Intensive Care Med. 2025. PMID: 39911077
-
Stratification of Bleeding Risk Using Thromboelastography in Children on Extracorporeal Membrane Oxygenation Support.Pediatr Crit Care Med. 2021 Mar 1;22(3):241-250. doi: 10.1097/PCC.0000000000002657. Pediatr Crit Care Med. 2021. PMID: 33512982
-
Use of Thromboelastography to Predict Thrombotic Complications in Pediatric and Neonatal Extracorporeal Membranous Oxygenation.J Extra Corpor Technol. 2018 Sep;50(3):149-154. J Extra Corpor Technol. 2018. PMID: 30250340 Free PMC article.
-
Platelet Count and Function during Pediatric Extracorporeal Membrane Oxygenation.Semin Thromb Hemost. 2020 Apr;46(3):357-365. doi: 10.1055/s-0040-1708542. Epub 2020 Mar 31. Semin Thromb Hemost. 2020. PMID: 32232826 Review.
-
Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion.Anesth Analg. 2014 Apr;118(4):731-43. doi: 10.1213/ANE.0000000000000115. Anesth Analg. 2014. PMID: 24651227 Review.
Cited by
-
Utilization of extracorporeal membrane oxygenation for a severe cardiocirculatory dysfunction recipient in liver transplantation: A case report.Medicine (Baltimore). 2018 Sep;97(37):e12407. doi: 10.1097/MD.0000000000012407. Medicine (Baltimore). 2018. PMID: 30213015 Free PMC article.
-
Activated Clotting Time and Haemostatic Complications in Patients Receiving ECMO Support: A Systematic Review.J Cardiovasc Dev Dis. 2025 Jul 13;12(7):267. doi: 10.3390/jcdd12070267. J Cardiovasc Dev Dis. 2025. PMID: 40710792 Free PMC article. Review.
-
A Look Ahead (from Behind).J Extra Corpor Technol. 2016 Jun;48(2):53-4. J Extra Corpor Technol. 2016. PMID: 27578893 Free PMC article. No abstract available.
-
Anticoagulation Management during First Five Days of Infant-Pediatric Extracorporeal Life Support.J Extra Corpor Technol. 2018 Mar;50(1):30-37. J Extra Corpor Technol. 2018. PMID: 29559752 Free PMC article.
-
Bleeding and Thrombosis With Pediatric Extracorporeal Life Support: A Roadmap for Management, Research, and the Future From the Pediatric Cardiac Intensive Care Society: Part 2.Pediatr Crit Care Med. 2019 Nov;20(11):1034-1039. doi: 10.1097/PCC.0000000000002104. Pediatr Crit Care Med. 2019. PMID: 31517728 Free PMC article. Review.
References
-
- Oliver W. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth. 2009;13:154–75. - PubMed
-
- Sidebotham D., McGeorge A., McGuinness S., Edwards M., Willcox T., Beca J.. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1–Overview of extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2009;23:886–92. - PubMed
-
- Nuttall G., Oliver W., Ereth M., Santrach P.. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:815–23. - PubMed
-
- Nuttall G., Oliver W., Santrach P., et al. . Algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology. 2001;94:773–81. - PubMed
-
- Welsby I. J., Jiao K., Ortel T. L., et al. . The kaolin-activated Thrombelastograph® predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth. 2006;20:531–5. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical